Skip to main content
Signal8

Perl Jessica

SEC insider (Form 3/4/5 filer). CIK 0002043716. SVP, General Counsel, Corp Sec at Emergent BioSolutions Inc. (EBS). 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 29, 2026. Located in GAITHERSBURG, MD.

Companies Perl Jessica has filed insider reports for

  • Emergent BioSolutions Inc. (EBS): Officer, SVP, General Counsel, Corp Sec
Perl Jessica profile photo

Perl Jessica

CIK: 0002043716

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Emergent BioSolutions Inc. logo
EBS

Emergent BioSolutions Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Apr 29, 2026
    Award
    Direct
    104.3K shares-
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 5, 2026
    Tax Payment
    Direct
    6.5K shares at avg. $8.44$55K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 3, 2026
    Award

    Employee Stock Option (Right to buy)

    Direct
    46.7K shares-
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Feb 9, 2026
    Tax Payment
    Direct
    918 shares at avg. $11.03$10K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 6, 2025
    Award
    Direct
    62.5K shares-
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Feb 9, 2025
    Tax Payment
    Direct
    918 shares at avg. $10.00$9K

1-6 of 6